Impact of continued administration of tolvaptan on cirrhotic patients with ascites
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2050-6511
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Impact of continued administration of tolvaptan on cirrhotic patients with ascites ; volume:19 ; number:1 ; day:18 ; month:12 ; year:2018 ; pages:1-9 ; date:12.2018
BMC pharmacology & toxicology ; 19, Heft 1 (18.12.2018), 1-9, 12.2018
- Creator
-
Kogiso, Tomomi
Sagawa, Takaomi
Kodama, Kazuhisa
Taniai, Makiko
Tokushige, Katsutoshi
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s40360-018-0277-3
- URN
-
urn:nbn:de:101:1-2019020622011281757898
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:53 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kogiso, Tomomi
- Sagawa, Takaomi
- Kodama, Kazuhisa
- Taniai, Makiko
- Tokushige, Katsutoshi
- SpringerLink (Online service)
Other Objects (12)
Management of cirrhotic patients with ascites
High mortality of pneumonia in cirrhotic patients with ascites
Tolvaptan treatment improves survival of cirrhotic patients with ascites and hyponatremia
Intravenous furosemide and human albumin for treatment of cirrhotic ascites: Useful or harmful?
The impact of large-volume paracentesis on renal haemodynamics in cirrhotic patients with ascites
Zinc deficiency correlates to spontaneous bacterial peritonitis in patients with cirrhotic ascites
Combination of PCT, sNFI and dCHC for the diagnosis of ascites infection in cirrhotic patients
Sodium restriction in patients with cirrhotic ascites: a protocol for a systematic review
Consensus care recommendations for alfapump® in cirrhotic patients with refractory or recurrent ascites
Empagliflozin as a novel therapy for cirrhotic refractory ascites: a randomized controlled study
Impaired Renal Function May Not Negate the Efficacy of Tolvaptan in the Treatment of Cirrhotic Patients with Refractory Ascites
Endoscopic ultrasound fine-needle aspiration of peritoneal deposits for diagnosis of tubercular peritonitis in a cirrhotic patient with ascites
Management of cirrhotic patients with ascites
High mortality of pneumonia in cirrhotic patients with ascites
Tolvaptan treatment improves survival of cirrhotic patients with ascites and hyponatremia
Intravenous furosemide and human albumin for treatment of cirrhotic ascites: Useful or harmful?
The impact of large-volume paracentesis on renal haemodynamics in cirrhotic patients with ascites
Zinc deficiency correlates to spontaneous bacterial peritonitis in patients with cirrhotic ascites
Combination of PCT, sNFI and dCHC for the diagnosis of ascites infection in cirrhotic patients
Sodium restriction in patients with cirrhotic ascites: a protocol for a systematic review
Consensus care recommendations for alfapump® in cirrhotic patients with refractory or recurrent ascites
Empagliflozin as a novel therapy for cirrhotic refractory ascites: a randomized controlled study
Impaired Renal Function May Not Negate the Efficacy of Tolvaptan in the Treatment of Cirrhotic Patients with Refractory Ascites
Endoscopic ultrasound fine-needle aspiration of peritoneal deposits for diagnosis of tubercular peritonitis in a cirrhotic patient with ascites
Management of cirrhotic patients with ascites
High mortality of pneumonia in cirrhotic patients with ascites
Tolvaptan treatment improves survival of cirrhotic patients with ascites and hyponatremia
Intravenous furosemide and human albumin for treatment of cirrhotic ascites: Useful or harmful?
The impact of large-volume paracentesis on renal haemodynamics in cirrhotic patients with ascites
Zinc deficiency correlates to spontaneous bacterial peritonitis in patients with cirrhotic ascites
Combination of PCT, sNFI and dCHC for the diagnosis of ascites infection in cirrhotic patients
Sodium restriction in patients with cirrhotic ascites: a protocol for a systematic review
Consensus care recommendations for alfapump® in cirrhotic patients with refractory or recurrent ascites
Empagliflozin as a novel therapy for cirrhotic refractory ascites: a randomized controlled study
Impaired Renal Function May Not Negate the Efficacy of Tolvaptan in the Treatment of Cirrhotic Patients with Refractory Ascites